Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News and Analysis
  • Published:

Big companies helped by safe harbour ruling

Nature Reviews Drug Discovery volume 4, pages 525–526 (2005)Cite this article

The US Supreme Court's decision on patent protection leaves an uncertain future for research tool companies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Simon Frantz
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Integra v. Merck: A mixed bag for research tool patents

US courts narrow patent exemptions

Momentous patent case may not be resolved anytime soon

https://doi.org/10.1038/nrd1652

Related external links

Supreme Court Merck vs. Integra

Patently-O: Patent Law Blog

Wikipedia: Merck vs. Integra

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frantz, S. Big companies helped by safe harbour ruling. Nat Rev Drug Discov 4, 525–526 (2005). https://doi.org/10.1038/nrd1789

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd1789

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing